Galimedix Therapeutics

Dry AMD / Glaucoma First-to-Market Drugs ]HealthcareBiotechnology / Life SciencesUSA, Israel$5,000,000Debt/Equity For important risk and disclaimer information, Click Here. Click to view Investor Presentation and/or Schedule Management Call. To Access DataRoom, click Download NDA. Overview Galimedix Therapeutics, Inc. (“Galimedix”) is a Phase 2 biopharma company with a novel first-in-class...

Continue reading


Hi. We're not around right now. But you can send us an email and we'll get back to you, asap.

Thanks, Ken

Ken Margolis | Managing Partner Castle Placement, LLC
1460 Broadway Street, Rte 400
New York, New York 10036
(212) 418-1188 | C: (516) 712-7784


Log in with your credentials

Forgot your details?